Skip to main content

Published locations for A real-world analysis finds no evidence of increased CV risk with tofacitinib vs. TNFi in RA

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. A real-world analysis finds no evidence of increased CV risk with tofacitinib vs. TNFi in RA

User login

  • Reset your password
  • /content/real-world-analysis-finds-no-evidence-increased-cv-risk-tofacitinib-vs-tnfi-ra
  • /rheumatology/article/252180/rheumatoid-arthritis/real-world-analysis-finds-no-evidence-increased-cv